Once again, scientists have created something to give humanoid robots skills that no human possesses without asking themselves if it is truly a good idea.
Swiss pharmaceutical giant Novartis announced Sunday it had agreed to buy Avidity Biosciences, with the San Diego-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback